Annual Accounts Payable
$400.00 K
-$10.30 K-2.51%
December 31, 2023
Summary
- As of February 7, 2025, BDRX annual accounts payable is $400.00 thousand, with the most recent change of -$10.30 thousand (-2.51%) on December 31, 2023.
- During the last 3 years, BDRX annual accounts payable has fallen by -$59.30 thousand (-12.91%).
- BDRX annual accounts payable is now -93.21% below its all-time high of $5.89 million, reached on December 1, 2019.
Performance
BDRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.14 M
+$1.74 M+434.05%
June 1, 2024
Summary
- As of February 7, 2025, BDRX quarterly accounts payable is $2.14 million, with the most recent change of +$1.74 million (+434.05%) on June 1, 2024.
- Over the past year, BDRX quarterly accounts payable has dropped by -$77.40 thousand (-3.50%).
- BDRX quarterly accounts payable is now -75.30% below its all-time high of $8.65 million, reached on June 1, 2017.
Performance
BDRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BDRX Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.5% | -3.5% |
3 y3 years | -12.9% | +420.6% |
5 y5 years | +10.2% | +420.6% |
BDRX Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -38.9% | at low | -3.5% | +434.1% |
5 y | 5-year | -93.2% | at low | -63.8% | +434.1% |
alltime | all time | -93.2% | +10.2% | -75.3% | +488.6% |
Biodexa Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $2.14 M(+434.0%) |
Dec 2023 | $400.00 K(-2.5%) | $400.00 K(-81.9%) |
Jun 2023 | - | $2.21 M(+439.5%) |
Dec 2022 | $410.30 K(-37.3%) | $410.30 K(-73.6%) |
Jun 2022 | - | $1.55 M(+137.2%) |
Dec 2021 | $654.60 K(+42.5%) | $654.60 K(-76.8%) |
Jun 2021 | - | $2.82 M(+514.1%) |
Dec 2020 | $459.30 K(-92.2%) | $459.30 K(-86.6%) |
Jun 2020 | - | $3.43 M(-41.8%) |
Dec 2019 | $5.89 M | $5.89 M(+84.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $3.20 M(+781.4%) |
Dec 2018 | $362.90 K(-88.2%) | $362.90 K(-91.9%) |
Jun 2018 | - | $4.50 M(+46.7%) |
Dec 2017 | $3.07 M(-23.6%) | $3.07 M(-64.5%) |
Jun 2017 | - | $8.65 M(+115.4%) |
Dec 2016 | $4.01 M(+18.6%) | $4.01 M(-48.5%) |
Jun 2016 | - | $7.79 M(+130.2%) |
Dec 2015 | $3.39 M(+121.7%) | $3.39 M(-30.4%) |
Jun 2015 | - | $4.86 M(+218.5%) |
Dec 2014 | $1.53 M(+77.4%) | $1.53 M |
Dec 2013 | $860.80 K | - |
FAQ
- What is Biodexa Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual accounts payable year-on-year change?
- What is Biodexa Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly accounts payable year-on-year change?
What is Biodexa Pharmaceuticals annual accounts payable?
The current annual accounts payable of BDRX is $400.00 K
What is the all time high annual accounts payable for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual accounts payable is $5.89 M
What is Biodexa Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, BDRX annual accounts payable has changed by -$10.30 K (-2.51%)
What is Biodexa Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of BDRX is $2.14 M
What is the all time high quarterly accounts payable for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly accounts payable is $8.65 M
What is Biodexa Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, BDRX quarterly accounts payable has changed by -$77.40 K (-3.50%)